Amid growing evidence suggesting circadian rhythms play a critical in the safety and efficacy of CAR T-cell therapy, ...
In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.
How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...
The company plans to begin enrolling the trial next quarter across eight US sites to test the vaccine as a monotherapy and in combination with Keytruda.
A new study in Nature Communications reveals how immune cells rapidly shut down their response after activation, preventing ...
Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.
Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...
The patient with significant bone marrow involvement had complete bone morphological remission. In this patient in which 95% ...
Biliary atresia (BA) is a life-threatening liver disease of infancy in which early surgery can restore bile flow but rarely ...
Published on January 6, 2026, in Volume 2 of the Immunity & Inflammation journal, the review begins by underscoring Professor Taniguchi's ...
The interferon regulatory factor (IRF) family of transcription factors, pivotal for initiating antiviral type I interferon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results